$AVXL I am extremely bullish on the data .. the FDA can ask any sorts of questions

Guys from the fda that really know their stuff.

He said Anavex could do that also and all of that makes Anavex pleased how easy the FDA wants to make Accelerated approval here.

The FDA and global agencies find great comfort in NDAs accompanied by a peer review.

look into Adamis Pharma, no more speculation, now it's real, two FDA approved meds, two major products, top of the line in comparison of their rivals, for cheaper price, AND WITH NO MUCH COMPETITION!

With all the scrutiny with on the FDA they will definitely be forced to approve Anavex which is the safest, cheapest on Healthcare and the patients, and most convenient drug.

$AVXL good thing they have 50 years of fda expertise on their staff, HandF😘

This puts alot of scrutiny on the FDA which is good for Anavex.

Suddenly the results could look golden and backed by the FDA allowable genetic coding regulations!!

$LIPO looking fantastic with the lockup agreement and multiple possible fda announcements due soon.

Another one with FDA news like r/s name, with good technical , reminds me of $RSLS $MSGM yesterday , which ran nice 7+ is the signal

Good FDA news -- stock is up!

we can hear about FDAs decision anyday starting Thursday..exciting times ahead

but a positive for the FDA as Dr. Stein looks at the label.

*******” another BIG reason why the FDA should approve it!!! !

Home run with FDA, path forward soon.

And some are saying oh its just an opinion, this is actually fantastic news for us and will open the door to other countries for approval and HOPEFULLY the US fda will approve it.

$AKBA We should be very happy at current recovery, Im holding the rest of my position right into partner, FDA the lot Yesterdays news was amazing

It is clean for the FDA.

This bodes very well for fda FDRR approval.

$AKBA FDA, please listen and read: “The benefit of Vafseo is its ability to correct haemoglobin levels in dialysis-dependent patients, with effects comparable to those seen with erythropoiesis-stimulating agents.